OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56

Pre-metastatic niche: formation, characteristics and therapeutic implication
Yuhang Wang, Jiachi Jia, Fuqi Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14

Targeting neutrophils: Mechanism and advances in cancer therapy
Shuaixi Yang, Jiachi Jia, Fuqi Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 13

Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1

Microbiome and pancreatic cancer: time to think about chemotherapy
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7

Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 6

Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review
Mengting Chen, Hongsen Liu, Yufei Xiao, et al.
Clinica Chimica Acta (2025), pp. 120176-120176
Closed Access

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4

Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
Eileen Tabrizi, Fatemeh Pourteymour Fard Tabrizi, Gehad Mahmoud Khaled, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 8

Prognostic value of the systemic immuno-inflammatory index in critically ill patients with vertebral fractures
Kaiya Zhang, Xia Li, Yaoyao Xu, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e36186-e36186
Open Access | Times Cited: 2

Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma
James Halle‐Smith, Hayden Pearce, Samantha M. Nicol, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 996-996
Open Access | Times Cited: 2

The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
T. P. Chris, Jack Y. Prochnau, A. Mediero Domínguez, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1979-1979
Open Access | Times Cited: 2

Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
Mundla Srilatha, Rama Rao Malla, Megha Priya Adem, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 12-20
Closed Access | Times Cited: 5

Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities
Zixuan Gou, Difei Zhang, Hongliang Cao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity
Yan Chen, Shuaiqi Feng, Ming Zhang, et al.
Journal of Inorganic Biochemistry (2024) Vol. 262, pp. 112766-112766
Closed Access | Times Cited: 1

Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 1

Intratumoral microbiota in orchestrating cancer immunotherapy response
Yutian Zou, Hanqi Zhang, Feng Liu, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 6, pp. 540-542
Closed Access | Times Cited: 1

Research Progress of miR-485-3p in Digestive System Tumors
家浩 孙
Advances in Clinical Medicine (2024) Vol. 14, Iss. 03, pp. 2240-2246
Closed Access

Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients
Zhouhua Li, Yue Wu, Weichang Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access

Silencing Exosomal circ102927 Inhibits Foot Melanoma Metastasis via Regulating Invasiveness, Epithelial-Mesenchymal Transition and Apoptosis
Huiying Wan, Ling Zhong, Tian Xia, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 825-839
Open Access

Cholesterol: The Driving Force Behind the Remodeling of Tumor Microenvironment in Colorectal Cancer
Ke Wang, Yuanyuan Zhang, Chengshuai Si, et al.
(2024)
Closed Access

Page 1 - Next Page

Scroll to top